Spliceosome and Neurodegeneration

Spliceosome and Neurodegeneration

The spliceosome is the sophisticated cellular machinery responsible for pre-mRNA splicing, the process by which introns are removed and exons are joined to produce mature messenger RNA. Mutations in splicing factors and dysregulation of spliceosome function are increasingly recognized as causative or contributory factors in various neurodegenerative diseases.

RNA Processing Diagram

Overview

The spliceosome is a large ribonucleoprotein complex composed of five small nuclear ribonucleoproteins (snRNPs) - U1, U2, U4, U5, and U6 - along with numerous associated proteins. This molecular machine catalyzes the removal of introns from pre-mRNA through two transesterification reactions. [@singh2021]

Key Components

Small Nuclear Ribonucleoproteins (snRNPs)

• U1 snRNP: Recognizes the 5' splice site
• U2 snRNP: Binds to the branch point sequence
• U4/U5/U6 tri-snRNP: Catalytic core of the spliceosome

Splicing Factors

• SF3B1: Component of U2 snRNP, mutated in some cancers and MDS
• U2AF: Auxiliary factor recognizing polypyrimidine tract and 3' splice site
• SRSF2: Serine/arginine-rich splicing factor 2
• hnRNPs: Heterogeneous nuclear ribonucleoproteins

Spliceosome and Neurodegeneration

The spliceosome is the sophisticated cellular machinery responsible for pre-mRNA splicing, the process by which introns are removed and exons are joined to produce mature messenger RNA. Mutations in splicing factors and dysregulation of spliceosome function are increasingly recognized as causative or contributory factors in various neurodegenerative diseases.

RNA Processing Diagram

Overview

The spliceosome is a large ribonucleoprotein complex composed of five small nuclear ribonucleoproteins (snRNPs) - U1, U2, U4, U5, and U6 - along with numerous associated proteins. This molecular machine catalyzes the removal of introns from pre-mRNA through two transesterification reactions. [@singh2021]

Key Components

Small Nuclear Ribonucleoproteins (snRNPs)

• U1 snRNP: Recognizes the 5' splice site
• U2 snRNP: Binds to the branch point sequence
• U4/U5/U6 tri-snRNP: Catalytic core of the spliceosome

Splicing Factors

• SF3B1: Component of U2 snRNP, mutated in some cancers and MDS
• U2AF: Auxiliary factor recognizing polypyrimidine tract and 3' splice site
• SRSF2: Serine/arginine-rich splicing factor 2
• hnRNPs: Heterogeneous nuclear ribonucleoproteins

Spliceosome Assembly Cycle

The spliceosome undergoes a dynamic assembly process: [@chen2022]

Disease Associations

Amyotrophic Lateral Sclerosis (ALS)

ALS is strongly linked to spliceosome dysfunction: [@liu2019]

TDP-43 Pathology

• [TDP-43](/mechanisms/tdp-43-proteinopathy) (encoded by TARDBP) is an RNA/DNA-binding protein
• Forms characteristic inclusions in 97% of ALS cases
• Regulates splicing of numerous target transcripts
• Mutations cause familial ALS

FUS Pathology

• FUS (Fused in Sarcoma) is another RNA-binding protein
• Mutations cause ~5% of familial ALS
• Disrupts splicing of specific gene transcripts
• Affects stress response and RNA metabolism

hnRNPA1

• Heterogeneous nuclear ribonucleoprotein A1
• Mutations linked to ALS and inclusion body myopathy
• Affects splicing of transcripts involved in cytoskeletal function

Frontotemporal Dementia (FTD)

• TDP-43 pathology in ~50% of FTD cases
• Overlap between ALS and FTD spectrum disorders
• Progranulin mutations affect splicing regulation

Spinal Muscular Atrophy (SMA)

• Caused by deficiency in SMN1 (Survival Motor Neuron 1)
• SMN2 backup gene produces mostly non-functional transcripts
• Therapies targeting SMN2 splicing (Spinraza, Risdiplam) are effective

Retinitis Pigmentosa

• PRPF31 mutations cause autosomal dominant RP
• Affects spliceosome function in photoreceptor cells
• Incomplete penetrance suggests modifier genes

Myelodysplastic Syndromes (MDS)

• SF3B1 mutations are common in MDS
• Associated with ring sideroblasts
• Links splicing to mitochondrial function

Molecular Mechanisms

Splicing Factor Aggregation

In neurodegeneration, splicing factors can form pathological aggregates: [@costemalelacoste2021]

• Stress granules containing TDP-43 and FUS
• Sequestration of normal splicing factors
• Disruption of RNA processing homeostasis

Alterations in Splicing Patterns

Neurodegenerative diseases show characteristic splicing changes: [@da2022]

• Inclusion of cryptic exons
• Exon skipping events
• Altered isoform ratios

RNA Transport Disruption

Splicing and transport are coupled:

• Defects in nuclear export
• Cytoplasmic mislocalization of transcripts
• Impaired local translation at synapses

Therapeutic Approaches

ASO Therapies

Antisense oligonucleotides can modulate splicing:

• Spinraza (nusinersen): Modifies SMN2 splicing for SMA
• ASOs targeting toxic splice products: In development for ALS/FTD
• Splice-switching oligonucleotides: Currently in clinical trials

Small Molecule Modulators

• splicing modulators in clinical trials
• Targeting specific splicing factors
• Modulating spliceosome assembly

Gene Therapy

• Viral delivery of corrected splicing factors
• CRISPR-based approaches to correct mutations
• Overexpression of protective splicing factors

Research Methods

• RNA-seq: Genome-wide splicing analysis
• CLIP-seq: Mapping RNA-protein interactions
• Minigene assays: Testing specific splicing events
• iPSC models: Patient-derived [neurons](/entities/neurons)

Spliceosome in Alzheimer's Disease

Emerging evidence links spliceosome dysfunction to AD pathogenesis. [@berson2022]

APP and Tau Splicing

Alternative splicing of APP and MAPT (tau) transcripts influences AD risk:

• APP splice variants containing exon 7 (KPI domain) are elevated in AD
• Tau exon 10 splicing produces 3R and 4R isoforms; dysregulation affects tau pathology
• splicing factors hnRNPs and SR proteins regulate these events

Aβ and Splicing

Aβ oligomers can alter spliceosome function:

• Disruption of nuclear speckle organization
• Mislocalization of splicing factors
• Global changes in alternative splicing patterns

Therapeutic Implications

Spliceosome-targeted approaches in AD:

• Modulating splicing of APP to reduce toxic Aβ isoforms
• Correcting tau exon 10 splicing imbalances
• Restoring splicing factor homeostasis

Spliceosome in Parkinson's Disease

PD research has uncovered connections to RNA processing: [@gao2022]

α-Synuclein and RNA Metabolism

• α-Synuclein can bind to RNA molecules
• Affects translation of specific mRNAs
• May disrupt ribosomal function

LRRK2 and Splicing

LRRK2 mutations (common in familial PD):

• May affect splicing factor phosphorylation
• Alters alternative splicing of target transcripts
• Links kinase signaling to RNA processing

PINK1 and Parkin

Mitophagy genes PINK1 and Parkin:

• Produce splice variants with altered function
• Splicing changes affect mitochondrial quality control

Spliceosome in Huntington's Disease

HD demonstrates dramatic splicing alterations: [@liu2021]

HTT Transcript Processing

• Expanded CAG repeats in HTT mRNA form toxic structures
• Aberrant splicing produces toxic peptide fragments
• Splicing factors sequestered into inclusions

Global Splicing Changes

RNA-seq studies reveal:

• Extensive exon skipping
• Cryptic exon inclusion
• Altered timing of splicing during development

Spliceosome in Prion Disease

Prion protein (PRNP) splicing is relevant: [@woebking2020]

Alternative Splicing of PRNP

• PRNP produces multiple splice variants
• Alternative isoforms may have protective roles
• Splicing dysregulation contributes to pathogenesis

Spliceosome in Spinal Muscular Atrophy

SMA represents a success story for spliceosome-targeted therapy: [@wirth2023]

SMN1 Deficiency

• Homozygous deletion or mutation of SMN1 causes SMA
• SMN protein essential for snRNP assembly
• Loss leads to widespread splicing defects

SMN2 as Therapeutic Target

• SMN2 produces mostly non-functional transcripts
• ASO drugs redirect splicing to include exon 7
• Spinraza, Risdiplam, and Evrysdi are FDA-approved

Mechanisms of ASO Therapy

Spliceosome in Retinitis Pigmentosa

PRPF31 mutations cause RP: [@tan2021]

Mechanism

• PRPF31 is a spliceosome component
• Photoreceptor cells particularly vulnerable
• Incomplete penetrance suggests modifier effects

Therapeutic Approaches

• Gene therapy to restore PRPF31 expression
• CRISPR correction of mutations

Spliceosome in Myelodysplastic Syndromes

SF3B1 mutations link splicing to blood disorders: [@kim2022]

SF3B1 and MDS

• Most common splicing factor mutation in MDS
• Associated with ring sideroblasts
• Affects mitochondrial iron metabolism

Therapeutic Implications

• Splicing modulators in clinical trials
• Targeting altered splicing in malignant cells

Spliceosome Assembly Dynamics

The spliceosome assembly follows a tightly regulated pathway: [@will2021]

Step-by-Step Assembly

Quality Control Mechanisms

• Exon junction complex (EJC) deposits on mRNA
• NMD (nonsense-mediated decay) targets transcripts with premature stop codons
• Spliceosome checkpoints ensure fidelity

Spliceosome and Stress Response

Stress granules and the spliceosome interact: [@mateju2022]

Stress Granule Formation

• Upon cellular stress, splicing factors redistribute
• TDP-43 and FUS localize to stress granules
• Prolonged stress leads to irreversible aggregation

Therapeutic Strategies

• Preventing stress granule formation
• Disaggregating existing granules
• Modulating stress response pathways

Splicing Factor Mutations in Neurodegeneration

TDP-43 (TARDBP)

• Over 50 mutations linked to ALS/FTD
• Predominantly in the C-terminal glycine-rich domain
• Affects RNA binding and splicing regulation

FUS (FUS)

• Over 40 mutations cause familial ALS
• NLS domain mutations cause cytoplasmic mislocalization
• Affects stress granule dynamics

hnRNPA1/A2

• Mutations cause inclusion body myopathy with Paget disease
• Affect prion-like aggregation properties
• Disrupt splicing of cytoskeletal genes

SFPQ and Other Factors

• SFPQ (splicing factor, proline/glutamine-rich) affected in ALS
• Altered splicing of neuronal genes
• Links to synaptic function

Biomarkers Based on Splicing Patterns

Splicing signatures could serve as biomarkers: [@baker2023]

ALS Biomarkers

• Distinct splicing patterns in patient blood/CSF
• Correlation with disease progression
• Potential for diagnostic use

AD Biomarkers

• APP and tau splicing variants
• May predict disease progression
• Useful for clinical trials

Experimental Models

Cell Culture Models

• iPSC-derived neurons from patients
• CRISPR-corrected isogenic lines
• Overexpression/knockdown of splicing factors

Animal Models

• Transgenic TDP-43 mice
• FUS mutant models
• SMN-deficient models for SMA

In Vitro Systems

• Recombinant spliceosome assembly
• Minigene reporters
• Single-molecule imaging

Future Directions

Single-Cell Splicing Analysis

• Cell-type specific splicing patterns
• Heterogeneity in diseased brains
• Links to neuronal vulnerability

Splicing-Modifying Therapies

• Enhanced ASO delivery to CNS
• Small molecules targeting specific factors
• Combination approaches with other modalities

Epigenetic Regulation of Splicing

Histone Modifications

Chromatin state influences splice site choice: [@luco2020]

• H3K36me3 promotes exon inclusion
• H3K4me3 marks active promoters affect first exon selection
• Histone readers like MRG15 connect chromatin to splicing

DNA Methylation

• Promoter methylation can alter splicing patterns
• Differential methylation in disease states

Non-coding RNAs

• Circular RNAs (circRNAs) can sponge splicing factors
• lncRNAs like MALAT1 regulate splicing factor activity

Splicing and Synaptic Function

Activity-Dependent Splicing

Neuronal activity modulates splicing: [@lee2021]

• Calcium influx activates splicing regulators
• Immediate early genes often have regulated splice variants
• Synaptic plasticity requires specific isoforms

Synaptic Splicing Factors

• Nova-1 regulates synaptic protein splicing
• Rbfox proteins control neuronal isoform expression
• Dysregulation affects synaptic function

Splicing in Neuropsychiatric Disorders

Altered splicing contributes to: [@zhang2022]

• Autism spectrum disorders
• Schizophrenia
• Intellectual disability

Clinical Applications

Diagnostic Splicing Tests

• RNA sequencing for diagnostic confirmation
• Splicing reporter assays
• Patient-specific splice site analysis

Pharmacogenomics

• Genetic variants affecting drug response
• Splicing-modifying drugs require careful monitoring

Biomarker Development

Splicing-based biomarkers offer several advantages: [@hernandez2023]

• Detectable in blood and CSF
• Reflect disease state
• Potentially predict treatment response

Splicing in Aging

Age-Related Splicing Changes

Aging affects spliceosome function: [@bhat2022]

• Global decline in splicing efficiency
• Increased cryptic splicing events
• Accumulation of splicing factor aggregates

Implications for Neurodegeneration

Age-related splicing changes may:

• Increase neuronal vulnerability
• Reduce adaptive capacity
• Promote protein aggregation

Cross-Linking

• [TDP-43 Proteinopathy](/mechanisms/tdp-43-proteinopathy)
• [FUS Proteinopathy](/mechanisms/fus-proteinopathy)
• [RNA Metabolism in Neurodegeneration](mechanisms/rna-metabolism)
• [ALS Pathway](/mechanisms/als-pathway)
• [AD Pathogenesis](/mechanisms/alzheimers-pathogenesis)
• [PD Pathogenesis](/mechanisms/parkinsons-pathogenesis)
• [Stress Granules](/mechanisms/stress-granules-neurodegeneration)
• [Microglia Neuroinflammation](/mechanisms/microglia-neuroinflammation)
• [Cellular Senescence](/mechanisms/cellular-senescence)
• [AMPK Signaling](/mechanisms/ampk-signaling-pathway)

Spliceosome Complex Structure

Major snRNP Components

The spliceosome consists of five core snRNPs: [@wahl2009]

U1 snRNP

• Composed of U1 snRNA and specific proteins
• Recognizes 5' splice site (GU)
• Contains U1-70K, U1-A, U1-C proteins

• U2 snRNA with SF3B1, SF3A proteins
• Binds branch point sequence
• Essential for spliceosome assembly

• U4 and U6 are base-paired
• U5 contacts 5' and 3' exons
• Catalytic core of spliceosome

Associated Proteins

Over 200 proteins associate with the spliceosome: [@matera2014]

• Splicing factors (SR proteins, hnRNPs)
• Kinases regulating splicing
• Helicases unwinding RNA
• Quality control proteins

Catalytic Steps

The splicing reaction proceeds in two transesterification steps:

• Forms lariat intermediate
• Releases 5' exon

• Joins exons
• Releases lariat intron

Spliceosome in Neurogenesis

Neuron-Specific Splicing

During neurodevelopment, splicing patterns shift dramatically: [@zhang2020]

• Embryonic isoforms replaced by adult forms
• Activity-dependent splicing factors increase
• Neuron-specific exons incorporated

splicing in Neural Progenitor Cells

NPCs show distinct splicing programs:

• Pluripotency factor splicing patterns
• Rapid transitions during differentiation
• Regulation by PTBP1 and PTBP2

Implications for Brain Development

Disrupted splicing during development can cause:

• Intellectual disability
• Autism spectrum disorders
• Developmental delays

Splicing and Mitochondrial Function

Mitochondrial RNA Processing

Mitochondria have their own splicing machinery: [@kuznetsova2021]

• Group I and II intron splicing
• tRNA processing
• RRNA modifications

Neurodegeneration Links

Mitochondrial splicing defects affect:

• Energy production
• Calcium homeostasis
• Apoptosis regulation

Therapeutic Targeting

Modulating splicing can improve mitochondrial function:

• Enhanced mitophagy
• Improved ATP production
• Reduced oxidative stress

Spliceosome and Autophagy

Splicing Factors in Autophagy

Autophagy regulation involves splicing: [@knupp2022]

• Alternative splicing of autophagy genes
• Regulation of mitophagy receptors
• LC3 lipidation machinery

Quality Control Pathways

Spliceosome and autophagy interact:

• Damaged splicing factors removed by autophagy
• Stress granules cleared via autophagy
• Protein aggregate removal requires both

Genetic Susceptibility

Spliceosome Gene Variants

Common variants in splicing genes affect disease risk: [@rohrer2023]

• hnRNPA1 variants in ALS
• FUS variants in FTD
• TARDBP variants in ALS/FTD

Penetrance Modifiers

Splicing factor polymorphisms modify disease onset:

• Age of onset variations
• Progression rates
• Phenotypic presentations

Comparative Biology

Evolutionary Conservation

Spliceosome components are highly conserved: [@grabowski2021]

• Yeast to human conservation
• Essential splicing factors
• Disease-related mutations

Model Organisms

Research benefits from diverse models:

• C. elegans for development
• Drosophila for genetics
• Zebrafish for development
• Mouse for disease modeling

Technical Advances

Long-Read Sequencing

Oxford Nanopore and PacBio enable: [@amarasinghe2022]

• Full-length isoform detection
• Splice variant quantification
• Novel isoform discovery

Single-Cell RNA-seq

Single-cell approaches reveal: [@hao2021]

• Cell-type specific splicing
• Heterogeneity in disease
• Development trajectories

Future Therapeutic Directions

RNA-Based Therapeutics

Next-generation RNA drugs: [@klein2023]

• Engineered ASOs with improved CNS delivery
• siRNA for specific splice sites
• Circular RNAs as therapeutics

Small Molecule Modulators

Drug-like molecules can: [@bates2022]

• Modulate specific splicing factors
• Cross blood-brain barrier
• Be optimized for potency

Combination Approaches

Future therapies may combine: [@s2024]

• Splicing modulators with gene therapy
• ASOs with small molecules
• Multiple ASO targets

Summary

The spliceosome represents a critical nexus for understanding neurodegenerative diseases. Its central role in RNA processing, combined with the discovery of disease-causing mutations in splicing factors, makes it an attractive therapeutic target. From the success of SMN2-splicing modifiers in SMA to emerging ASO therapies for ALS, spliceosome-targeted approaches are translating from bench to bedside. Continued research into spliceosome biology promises new treatments for AD, PD, HD, and other neurodegenerative disorders.

See Also

• [RNA Processing](/mechanisms/rna-processing)
• [RNA Stability and Decay](/mechanisms/rna-stability-and-decay)
• [TDP-43 Proteinopathy](/mechanisms/tdp-43-proteinopathy)
• [FUS Proteinopathy](/mechanisms/fus-proteinopathy)
• [SMN Complex](/mechanisms/smn-complex)
• [Spinal Muscular Atrophy](/diseases/spinal-muscular-atrophy)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Frontotemporal Dementia](/diseases/frontotemporal-dementia)

External Links

• [Spliceosome - Wikipedia](https://en.wikipedia.org/wiki/Spliceosome)
• [UniProt: SF3B1](https://www.uniprot.org/uniprot/Q755G3)
• [UniProt: SMN1](https://www.uniprot.org/uniprot/Q9UHA0)
• [NCBI Gene: SF3B1](https://www.ncbi.nlm.nih.gov/gene/6762)
• [NCBI Gene: SMN1](https://www.ncbi.nlm.nih.gov/gene/6609)
• [COSMIC: Splicing factor mutations in cancer](https://cancer.sanger.ac.uk/cosmic)

Recent Research Updates (2024-2026)

• [S et al. 2024: Capturing totipotency in human cells through spliceosomal repression.](https://pubmed.ncbi.nlm.nih.gov/38843832/)
• [MK et al. 2024: Mechanism for the initiation of spliceosome disassembly.](https://pubmed.ncbi.nlm.nih.gov/38925148/)
• [TJ et al. 2024: Emerging and re-emerging themes in co-transcriptional pre-mRNA splicin](https://pubmed.ncbi.nlm.nih.gov/39366353/)
• [Y et al. 2024: De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopment](https://pubmed.ncbi.nlm.nih.gov/38991538/)
• [ME et al. 2024: Transcriptome-wide splicing network reveals specialized regulatory fun](https://pubmed.ncbi.nlm.nih.gov/39480945/)

References